These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

718 related items for PubMed ID: 15588741

  • 1. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels.
    Willke RJ, Burke LB, Erickson P.
    Control Clin Trials; 2004 Dec; 25(6):535-52. PubMed ID: 15588741
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Current status of patient-reported outcomes in industry-sponsored oncology clinical trials and product labels.
    Gondek K, Sagnier PP, Gilchrist K, Woolley JM.
    J Clin Oncol; 2007 Nov 10; 25(32):5087-93. PubMed ID: 17991926
    [Abstract] [Full Text] [Related]

  • 5. Patient-reported outcomes supporting anticancer product approvals.
    Rock EP, Kennedy DL, Furness MH, Pierce WF, Pazdur R, Burke LB.
    J Clin Oncol; 2007 Nov 10; 25(32):5094-9. PubMed ID: 17991927
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Reasons for rejection of patient-reported outcome label claims: a compilation based on a review of patient-reported outcome use among new molecular entities and biologic license applications, 2006-2010.
    DeMuro C, Clark M, Mordin M, Fehnel S, Copley-Merriman C, Gnanasakthy A.
    Value Health; 2012 May 10; 15(3):443-8. PubMed ID: 22583454
    [Abstract] [Full Text] [Related]

  • 8. Patient-reported outcomes (PROs) in dental clinical trials and product development: introduction to scientific and regulatory considerations.
    Gwaltney CJ.
    J Evid Based Dent Pract; 2010 Jun 10; 10(2):86-90. PubMed ID: 20466315
    [Abstract] [Full Text] [Related]

  • 9. Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards.
    Cleeland CS, Sloan JA, ASCPRO Organizing Group.
    J Pain Symptom Manage; 2010 Jun 10; 39(6):1077-85. PubMed ID: 20538189
    [Abstract] [Full Text] [Related]

  • 10. Health-related quality of life measurement in symptom management trials.
    Ganz PA, Goodwin PJ.
    J Natl Cancer Inst Monogr; 2007 Jun 10; (37):47-52. PubMed ID: 17951231
    [Abstract] [Full Text] [Related]

  • 11. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative.
    Garcia SF, Cella D, Clauser SB, Flynn KE, Lad T, Lai JS, Reeve BB, Smith AW, Stone AA, Weinfurt K.
    J Clin Oncol; 2007 Nov 10; 25(32):5106-12. PubMed ID: 17991929
    [Abstract] [Full Text] [Related]

  • 12. Challenges to use of health-related quality of life for Food and Drug Administration approval of anticancer products.
    Rock EP, Scott JA, Kennedy DL, Sridhara R, Pazdur R, Burke LB.
    J Natl Cancer Inst Monogr; 2007 Nov 10; (37):27-30. PubMed ID: 17951228
    [Abstract] [Full Text] [Related]

  • 13. Development and validation of patient-reported outcomes measures for overactive bladder: a review of concepts.
    Coyne KS, Tubaro A, Brubaker L, Bavendam T.
    Urology; 2006 Aug 10; 68(2 Suppl):9-16. PubMed ID: 16908336
    [Abstract] [Full Text] [Related]

  • 14. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001.
    Acquadro C, Berzon R, Dubois D, Leidy NK, Marquis P, Revicki D, Rothman M, PRO Harmonization Group.
    Value Health; 2003 Aug 10; 6(5):522-31. PubMed ID: 14627058
    [Abstract] [Full Text] [Related]

  • 15. The patient-reported outcome (PRO) consortium: filling measurement gaps for PRO end points to support labeling claims.
    Coons SJ, Kothari S, Monz BU, Burke LB.
    Clin Pharmacol Ther; 2011 Nov 10; 90(5):743-8. PubMed ID: 21993428
    [Abstract] [Full Text] [Related]

  • 16. Patient-reported outcomes for acute graft-versus-host disease prevention and treatment trials.
    Lee SJ, Williams LA.
    Biol Blood Marrow Transplant; 2010 Mar 10; 16(3):295-300. PubMed ID: 19747556
    [Abstract] [Full Text] [Related]

  • 17. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE, Kleijnen J.
    Eur J Health Econ; 2008 Nov 10; 9 Suppl 1():5-29. PubMed ID: 18987905
    [Abstract] [Full Text] [Related]

  • 18. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.
    U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health.
    Health Qual Life Outcomes; 2006 Oct 11; 4():79. PubMed ID: 17034633
    [Abstract] [Full Text] [Related]

  • 19. The prognostic significance of patient-reported outcomes in cancer clinical trials.
    Gotay CC, Kawamoto CT, Bottomley A, Efficace F.
    J Clin Oncol; 2008 Mar 10; 26(8):1355-63. PubMed ID: 18227528
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.